Naylor S - Search Results

1

Characterization of physiologically regulated vectors for the treatment of ischemic disease.

Boast K, Binley K, Iqball S, Price T, Spearman H, Kingsman S, Kingsman A, Naylor S. Boast K, et al. Among authors: naylor s. Hum Gene Ther. 1999 Sep 1;10(13):2197-208. doi: 10.1089/10430349950017185. Hum Gene Ther. 1999. PMID: 10498251

2

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.

Binley K, Askham Z, Iqball S, Spearman H, Martin L, de Alwis M, Thrasher AJ, Ali RR, Maxwell PH, Kingsman S, Naylor S. Binley K, et al. Among authors: naylor s. Blood. 2002 Oct 1;100(7):2406-13. doi: 10.1182/blood-2002-02-0605. Blood. 2002. PMID: 12239150 Free article.

3

Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors.

Nicoud M, Kong J, Iqball S, Kan O, Naylor S, Gouras P, Allikmets R, Binley K. Nicoud M, et al. Among authors: naylor s. J Gene Med. 2007 Dec;9(12):1015-23. doi: 10.1002/jgm.1115. J Gene Med. 2007. PMID: 17963276

4

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer.

Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S. Binley K, et al. Among authors: naylor s. Gene Ther. 1999 Oct;6(10):1721-7. doi: 10.1038/sj.gt.3301001. Gene Ther. 1999. PMID: 10516721

5

The macrophage - a novel system to deliver gene therapy to pathological hypoxia.

Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P, Lewis C, Harris A, Kingsman S, Naylor S. Griffiths L, et al. Among authors: naylor s. Gene Ther. 2000 Feb;7(3):255-62. doi: 10.1038/sj.gt.3301058. Gene Ther. 2000. PMID: 10694803

6

Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer.

Kan O, Griffiths L, Baban D, Iqball S, Uden M, Spearman H, Slingsby J, Price T, Esapa M, Kingsman S, Kingsman A, Slade A, Naylor S. Kan O, et al. Among authors: naylor s. Cancer Gene Ther. 2001 Jul;8(7):473-82. doi: 10.1038/sj.cgt.7700329. Cancer Gene Ther. 2001. PMID: 11498768

7

Hypoxia-mediated tumour targeting.

Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S, Naylor S. Binley K, et al. Among authors: naylor s. Gene Ther. 2003 Apr;10(7):540-9. doi: 10.1038/sj.gt.3301944. Gene Ther. 2003. PMID: 12646859

8

Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization.

Bainbridge JW, Mistry A, Binley K, De Alwis M, Thrasher AJ, Naylor S, Ali RR. Bainbridge JW, et al. Among authors: naylor s. Gene Ther. 2003 Jun;10(12):1049-54. doi: 10.1038/sj.gt.3301945. Gene Ther. 2003. PMID: 12776163

9

Cytochrome P450-based cancer gene therapy: current status.

Kan O, Kingsman S, Naylor S. Kan O, et al. Among authors: naylor s. Expert Opin Biol Ther. 2002 Dec;2(8):857-68. doi: 10.1517/14712598.2.8.857. Expert Opin Biol Ther. 2002. PMID: 12517265 Review.

10

Exploiting the hypoxia response.

Binley K, Kan O, White J, Naylor S. Binley K, et al. Among authors: naylor s. Curr Opin Mol Ther. 2003 Dec;5(6):650-6. Curr Opin Mol Ther. 2003. PMID: 14755892 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters